Proton NMR spectroscopy is emerging from translational and preclinical neuroscience
research as an important tool for evidence based diagnosis and therapy monitoring. It …

Purpose Hyperglycemia has been associated with poor outcomes in many disease states.
This retrospective study assessed the association between hyperglycemia and survival in …

Objectives Glioblastoma multiforme (GBM), the most aggressive glial brain tumors, can
metabolize glucose through glycolysis and mitochondrial oxidation pathways. While specific …

In the management of glioblastoma (GBM), there is a considerable predisposition to
hyperglycemia due to significant integration of corticosteroid therapy to treat predictable …

Glioblastoma (GBM) causes poor survival in patients even with aggressive treatment.
Temozolomide (TMZ) is the standard chemotherapeutic choice for GBM treatment but …

Glioblastomas (GBs) are malignant brain tumours with poor prognosis even after aggressive
therapy. Programmed cell death-1 (PD-1) immune checkpoint blockade is a promising …

Background DCE@ urLAB is a software application for analysis of dynamic contrast-
enhanced magnetic resonance imaging data (DCE-MRI). The tool incorporates a friendly …

OBJECTIVES: As a unique tool to assess metabolic fluxes noninvasively, 13C magnetic
resonance spectroscopy (MRS) could help to characterize and understand malignancy in …

Simple Summary Glioblastoma (GB) is a malignant brain tumour with no cure, even after the
best treatment. The evaluation of a therapy response is usually based on magnetic …

Glioblastomas (GB) are brain tumours with poor prognosis even after aggressive therapy.
Improvements in both therapeutic and follow‐up strategies are urgently needed. In previous …